Hepatic iron accumulation may be associated with insulin resistance in patients with chronic hepatitis C

Hepatology Research

Volumn 37, Issue 11, 2007, Pages 932-940

  Sumida, Yoshio ^a   Kanemasa, Kazuyuki ^a   Fukumoto, Kohei ^a   Yoshida, Naohisa ^a   Sakai, Kyoko ^a  

^a Nara City Hospital   (Japan)

Author keywords

Fasting plasma glucose; Ferritin; Hepatitis C virus; Homeostasis model assessment for insulin resistance; Immunoreactive insulin; Iron

Indexed keywords

FERRITIN; HEPATITIS C ANTIBODY; INSULIN; IRON; LIVER PROTECTIVE AGENT;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 34548644734     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00152.x     Document Type: Article

References (38)

1. Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
2. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
3. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
4. Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C: Virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
5. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/ PI3-kinease signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-92.
6. Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C: Virus down-regulate insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165: 1499-508.
7. Hui JM, Sud A, Farrell GC et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003; 125: 1695-704.
8. Romero-Gomez M, Del Mar Viloria M, Andrade RJ et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 12: 636-41.
9. D'Souza R, Sabin CA, Foster GR. Insulin resistance plays a role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol 2005; 100: 1509-15.
10. Farinati F, Cardin R, De Maria N et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 449-56.
11. Bonkovsky HL, Banner BF, Rothman AL. Iron and chronic viral hepatitis. Hepatology 1997; 25: 759-68.
12. Sumida Y, Nakashima T, Yoh T et al. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 2000; 33: 616-22.
13. Hayashi H, Takikawa T, Nishimura N, Yano M, Isomura T, Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 1994; 89: 986-8.
14. Iwasa M, Kaito M, Ikoma J et al. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients. Hepatogastroenterology 2002; 49: 537-9.
15. Yano M, Hayashi H, Yoshioka K et al. A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: A multicenter, prospective, randomized, controlled trial in Japan. J Gastroenterol 2004; 39: 570-4.
16. Furutani M, Nakashima T, Sumida Y et al. Insulin resitance/β cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection. Liver Int 2003; 23: 294-9.
17. Sumida Y, Nakashima T, Yoh T et al. Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases. Liver 2001; 21: 295-9.
18. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplication and antibody testing. J Clin Microbiol 1995; 33: 654-7.
19. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 1994; 19: 1347-53.
20. Ichida F, Tsuji T, Omata M et al. New Inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996; 6: 112-19.
21. Knodell RG, Ishak KG, Bilack WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
22. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102: 2108-13.
23. Hickman IJ, Powell EE, Prins JB, Clouston AD, Ash S, Purdie DM, Jonsson JR. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy. J Hepatol 2003; 39: 1042-8.
24. Fartoux L, Poujol-Robert A, Guechot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54: 1003-8.
25. Paradis V, Perlemuter G, Bonvoust F et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 2001; 34: 738-44.
26. Ferrarini E. Insulin resistance, iron, and the liver. Lancet 2000; 355: 2182-2.
27. Fernandez-Real JM, Lopez-Bermejo Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002; 51: 2348-54.
28. Niederau C, Berger M, Stremmel W et al. Hyperinsulinemia in non-cirrhotic haemochromatosis: Impaired hepatic insulin degradation? Diabetologia 1984; 26: 441-4.
29. Fargion S, Dongiovanni P, Guzzo A, Colombo S, Valenti L, Fracanzani AL. Iron and insulin resistance. Aliment Pharamacol Ther 2005; 22 (Suppl 2): 61-63.
30. Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261: 8708-11.
31. Mendler MH, Turlin B, Moirand R et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-63.
32. Haap M, Fritsche A, Mensing HJ, Haring HU, Stumvoll M. Association of high serum ferritin concentration with glucose intolerance and insulin resistance in healthy people. Ann Intern Med 2003; 139: 869-671.
33. Iwasaki T, Nakajima A, Yoneda M et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care 2005; 28: 2486-91.
34. Jehn M, Clark JM, Guallar E. Serum ferritin level and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004; 27: 2422-8.
35. Elsammak M, Refai W, Elsawafi A, Abdel-Fattah I, Abd Elatti E, Ghazal A et al. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients. Curr Med Res Opin 2005; 21: 527-34.
36. Shaheen M, Echeverry D, Oblad MG, Montoya MI, Teklehaimanot S, Akhtar AJ. Hepatitis C: Metabolic syndrome, andRinflammatory markers: results from the third national health and nutrition examination survey. Diabetes Res Clin Pract 2006; 16: 320-6.
37. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function. Diabetes 2002; 51: 1000-4.
38. Facchini FS, Hua NW, Stoohs RA. Effect of iron reduction in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 931-9.